Cargando…

Serum thymidine kinase 1 protein concentration for predicting early progression and monitoring the response to TACE in hepatocellular carcinomas: a network meta-analysis

AIM: A meta-analysis was conducted to evaluate the clinical significance of serum thymidine kinase 1 protein concentration (STK1p) in distinguishing between hepatocellular carcinomas (HCC) and non-HCC for predicting early progression and monitoring the response to transarterial chemoembolization in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Hongbo, Hei, Ailian, Zhou, Ji, He, Ellen, Skog, Sven, Li, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256325/ https://www.ncbi.nlm.nih.gov/pubmed/34258026 http://dx.doi.org/10.2144/fsoa-2021-0016

Ejemplares similares

A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment
por: Dang, Li, et al.
Publicado: (2020)

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?
por: Fang, Yujing, et al.
Publicado: (2023)

Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery
por: Wang, Xiangbin, et al.
Publicado: (2023)

Investigation on Cell Proliferation with a New Antibody against Thymidine Kinase 1
por: Wang, Naining, et al.
Publicado: (2001)

Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer
por: CHEN, FEIYU, et al.
Publicado: (2013)

Serum thymidine kinase in acute leukaemia.
por: Hagberg, H., et al.
Publicado: (1984)

Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer
por: Lundgren, Per‐Olof, et al.
Publicado: (2022)

The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
por: Kim, Jung Hee, et al.
Publicado: (2017)

Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression
por: Zou, Xinhua, et al.
Publicado: (2021)

TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
por: Lu, Haohao, et al.
Publicado: (2023)

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2017)

THYMIDINE TRIPHOSPHATE SYNTHESIS IN TETRAHYMENA : I. Studies on Thymidine Kinase
por: Shoup, G. D., et al.
Publicado: (1966)

INDUCIBILITY OF THYMIDINE KINASE BY THYMIDINE AS A FUNCTION OF INTERPHASE STAGE
por: Hotta, Yasuo, et al.
Publicado: (1965)

Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot Assay
por: Chen, Zhi Heng, et al.
Publicado: (2011)

Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipiodol (cTACE)
por: Wiggermann, Philipp, et al.
Publicado: (2011)

Quaternary structures of recombinant, cellular, and serum forms of Thymidine Kinase 1 from dogs and humans
por: Hanan, Sharif, et al.
Publicado: (2012)

Thymidine kinase in breast cancer.
por: Robertson, J. F., et al.
Publicado: (1990)

Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis
por: Duan, Ruihua, et al.
Publicado: (2023)

Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
por: Matikas, A., et al.
Publicado: (2021)

Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
por: Mattsson Ulfstedt, Johan, et al.
Publicado: (2021)

Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE?
por: Ge, Naijian, et al.
Publicado: (2023)

Thymidine kinase activities in mononuclear leukocytes and serum from breast cancer patients.
por: McKenna, P. G., et al.
Publicado: (1988)

TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial
por: Féray, Cyrille, et al.
Publicado: (2023)

3'-Amino thymidine affinity matrix for the purification of herpes simplex virus thymidine kinase.
por: Tung, P. P., et al.
Publicado: (1996)

Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation
por: Alegre, Melissa M., et al.
Publicado: (2012)

Development of TACE Refractoriness Scores in Hepatocellular Carcinoma
por: Chen, Li, et al.
Publicado: (2021)

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)
por: Bergqvist, Mattias, et al.
Publicado: (2023)

Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer
por: Carlsson, Lena, et al.
Publicado: (2009)

Thymidine Kinase Type 1 and C‐Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer
por: Selting, K.A., et al.
Publicado: (2016)

Comparison of plasma and tissue thymidine kinase activities.
por: Calvert, R. J., et al.
Publicado: (1989)

Quaternary structure of vaccinia virus thymidine kinase
por: Black, Margaret E., et al.
Publicado: (1990)

Impact of serum C-reactive protein level on the prognosis of patients with hepatocellular carcinoma undergoing TACE
por: Jun, Chung Hwan, et al.
Publicado: (2013)

ACQUISITION OF CHICK CYTOSOL THYMIDINE KINASE ACTIVITY BY THYMIDINE KINASE-DEFICIENT MOUSE FIBROBLAST CELLS AFTER FUSION WITH CHICK ERYTHROCYTES
por: Kit, Saul, et al.
Publicado: (1974)

Transcatheter arterial chemoembolization (TACE) combined with γ-knife compared to TACE or γ-knife alone for hepatocellular carcinoma
por: Cai, Yeyu, et al.
Publicado: (2018)

Transcatheter arterial chemoembolisation (TACE) plus S-1 for the treatment of BCLC stage B hepatocellular carcinoma refractory to TACE
por: Huang, Wu-Kui, et al.
Publicado: (2017)

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience
por: Abdelrahim, Maen, et al.
Publicado: (2022)

Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma
por: Wang, Yujia, et al.
Publicado: (2022)

Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect
por: Zhang, Qiang, et al.
Publicado: (2019)

STK1p as a prognostic biomarker for overall survival in non-small-cell lung carcinoma, based on real-world data
por: Wang, Zhenxin, et al.
Publicado: (2020)

Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects, Translational Progress, and Emerging Therapies
por: Berardo, Andres, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6rh5hdq438svjvn6ofm986d7c